FDX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FedEx Corp (FDX) is currently not an optimal buy for a beginner investor with a long-term strategy. While the company has shown strong financial performance and positive growth trends, the recent price decline, negative technical indicators, and mixed analyst ratings suggest waiting for a better entry point. Additionally, options data indicates bearish sentiment, and there are no strong proprietary trading signals to support an immediate buy decision.
The MACD is negatively expanding (-3.106), indicating bearish momentum. RSI is at 33.603, which is neutral but nearing oversold territory. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below key support levels (S1: 374.599). The stock's recent price decline (-2.80% in the regular market) suggests caution.
Strong financial performance in Q2 2026: Revenue increased by 6.84% YoY, Net Income up 29.23% YoY, and EPS up 33.66% YoY.
Positive long-term strategic updates during Investor Day, including improved cost management and free cash flow.
Several analysts have raised price targets, with some projecting values as high as $479.
Recent price decline (-2.80% in the regular market).
Mixed analyst ratings, with some downgrades citing expensive valuations and potential earnings decline in upcoming quarters.
Bearish sentiment in options trading data.
No recent congress trading data or influential figure transactions to support a buy decision.
FedEx reported strong Q2 2026 financials: Revenue increased to $23.47B (up 6.84% YoY), Net Income rose to $955M (up 29.23% YoY), EPS increased to $4.05 (up 33.66% YoY), and Gross Margin improved to 66.59% (up 1.19% YoY). These results reflect effective cost management and demand improvement.
Analyst ratings are mixed. Jefferies raised the price target to $450 and maintains a Buy rating, citing the company's strong physical asset network. However, HSBC downgraded the stock to Reduce with a $335 price target, citing expensive valuations and potential earnings decline. Other analysts have raised price targets but remain cautious about macroeconomic and competitive risks.
